Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03010995Phase 1Withdrawn
Phase 1, randomised, double-blind trial of nicotine, sponsored by University of Louisville. Primary endpoint: Endothelial function. Planned start Mar 2018; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03010995.